Enterocolitis induced by autoimmune targeting of enteric glial cells: A possible mechanism in Crohn's disease?

被引:255
作者
Cornet, A
Savidge, TC
Cabarrocas, J
Deng, WL
Colombel, JF
Lassmann, H
Desreumaux, P
Liblau, RS
机构
[1] Univ Paris 06, INSERM U546, F-75013 Paris, France
[2] Univ Paris 06, Immunol Lab, F-75013 Paris, France
[3] Massachusetts Gen Hosp, Combined Program Pediat Gastroenterol & Nutr, Boston, MA 02129 USA
[4] Harvard Univ, Sch Med, Boston, MA 02129 USA
[5] CHU Lille, INSERM, Equipe Mixte, Inflammatory Bowel Dis Lab, F-59000 Lille, France
[6] Univ Vienna, Brain Res Inst, Dept Neuroimmunol, A-1090 Vienna, Austria
关键词
D O I
10.1073/pnas.231474098
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Early pathological manifestations of Crohn's disease (CID) include vascular disruption, T cell infiltration of nerve plexi, neuronal degeneration, and induction of T helper 1 cytokine responses. This study demonstrates that disruption of the enteric glial cell network in CID patients represents another early pathological feature that may be modeled after CD8(+) T cell-mediated autoimmune targeting of enteric glia in double transgenic mice. Mice expressing a viral neoself antigen in astrocytes and enteric glia were crossed with specific T cell receptor transgenic mice, resulting in apoptotic depletion of enteric glia to levels comparable in CD patients. Intestinal and mesenteric T cell infiltration, vasculitis, T helper 1 cytokine production, and fulminant bowel inflammation were characteristic hallmarks of disease progression. Immune-mediated damage to enteric glia therefore may participate in the initiation and/or the progression of human inflammatory bowel disease.
引用
收藏
页码:13306 / 13311
页数:6
相关论文
共 50 条
[1]   Tumor-specific killer cells in paraneoplastic cerebellar degeneration [J].
Albert, ML ;
Darnell, JC ;
Bender, A ;
Francisco, LM ;
Bhardwaj, N ;
Darnell, RB .
NATURE MEDICINE, 1998, 4 (11) :1321-1324
[2]   An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].
Asseman, C ;
Mauze, S ;
Leach, MW ;
Coffman, RL ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003
[3]  
Benyahia B, 1999, ANN NEUROL, V45, P162, DOI 10.1002/1531-8249(199902)45:2<162::AID-ANA5>3.0.CO
[4]  
2-R
[5]   Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage [J].
Bercovici, N ;
Heurtier, A ;
Vizler, C ;
Pardigon, N ;
Cambouris, C ;
Desreumaux, P ;
Liblau, R .
JOURNAL OF IMMUNOLOGY, 2000, 165 (01) :202-210
[6]   ISOLATION, IDENTIFICATION, AND CULTURE OF NORMAL MOUSE COLONIC GLIA [J].
BERNSTEIN, CN ;
VIDRICH, A .
GLIA, 1994, 12 (02) :108-116
[7]   NEUROFILAMENT AND GLIAL FIBRILLARY ACID PROTEIN-RELATED IMMUNOREACTIVITY IN RODENT ENTERIC NERVOUS-SYSTEM [J].
BJORKLUND, H ;
DAHL, D ;
SEIGER, A .
NEUROSCIENCE, 1984, 12 (01) :277-287
[8]   Animal models of mucosal inflammation and their relation to human inflammatory bowel disease [J].
Blumberg, RS ;
Saubermann, LJ ;
Strober, W .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (06) :648-656
[9]   Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4 [J].
Boirivant, M ;
Fuss, IJ ;
Chu, A ;
Strober, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) :1929-1939
[10]   GFAP PROMOTER DIRECTS ASTROCYTE-SPECIFIC EXPRESSION IN TRANSGENIC MICE [J].
BRENNER, M ;
KISSEBERTH, WC ;
SU, Y ;
BESNARD, F ;
MESSING, A .
JOURNAL OF NEUROSCIENCE, 1994, 14 (03) :1030-1037